Company
Tyra Biosciences, Inc.
TYRA · CIK 0001863127
Acquisition (code A) of 951 shares at $9.129 per share.
Reporting Person Fuhrman Alan · Officer Title Chief Financial Officer · Transaction Code A
Traded Sep 15, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001193125-26-394731 · filed 2026-09-17 · View filing →
Acquisition (code A) of 2,925 shares at $9.129 per share.
Reporting Person Rueb Yuliya · Officer Title Vice President, Finance (PAO) · Transaction Code A
Traded Sep 15, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001193125-26-394734 · filed 2026-09-17 · View filing →
Acquisition (code A) of 864 shares at $9.129 per share.
Reporting Person Harris Todd · Officer Title President and CEO · Transaction Code A
Traded Sep 15, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001193125-26-394738 · filed 2026-09-17 · View filing →
Purchase of 971.8943 shares at $20.5784 per share.
Reporting Person Verjee Rehan · Transaction Code P
Traded Sep 9, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001193125-26-389333 · filed 2026-09-11 · View filing →